| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a07a4218869b7bd6876311f9a8be197 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-864 |
| filingDate |
2022-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd1fe19f1707df870269bac5ca979a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_079a5dd981aa0aea8e7d0a5b6b43bd1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bda0af9bd923e8b7c10ac70d740ce24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7074d34d7fe59277af75c99f183642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b0759249ccf5bf56c5c80dbdaf40604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365f22d67b5a3e4af945e80627d42d72 |
| publicationDate |
2022-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022253162-A1 |
| titleOfInvention |
Use of long-chain non-coding rna-neat1, and adeno-associated virus overexpressing rna-neat1 and use thereof |
| abstract |
Provided are the use of long-chain non-coding RNA-NEAT1, and sgRNA and an adeno-associated virus overexpressing RNA-NEAT1 and the use thereof, which belong to the technical field of medicines. Provided is the use of the long-chain non-coding RNA-NEAT1 in the preparation of a drug for treating Fuchs' endothelial corneal dystrophy. The overexpression of the long-chain non-coding RNA-NEAT1 can effectively reduce corneal endothelial injury and relieve corneal edema symptoms, and the long-chain non-coding RNA-NEAT1 can be used for treating Fuchs' endothelial corneal dystrophy. |
| priorityDate |
2021-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |